Entera Bio Ltd. (ENTX)
Automate Your Wheel Strategy on ENTX
With Tiblio's Option Bot, you can configure your own wheel strategy including ENTX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ENTX
- Rev/Share 0.0026
- Book/Share 0.3235
- PB 6.8622
- Debt/Equity 0.0139
- CurrentRatio 10.8256
- ROIC -0.1534
- MktCap 101787593.0
- FreeCF/Share 0.0101
- PFCF 214.2901
- PE -41.7656
- Debt/Assets 0.0121
- DivYield 0
- ROE -0.167
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 2
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference
Published: November 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
JERUSALEM, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies, today announced that the Company's Chief Executive Officer, Miranda Toledano, will be participating in a fireside chat at the 8th Annual Evercore ISI Healthcare Conference, details as below.
Read More
Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
ENTX posts positive PK data for its first oral GLP-2 therapy, signaling a potential breakthrough in short bowel syndrome treatment.
Read More
About Entera Bio Ltd. (ENTX)
- IPO Date 2018-06-28
- Website https://www.enterabio.com
- Industry Biotechnology
- CEO Miranda J. Toledano
- Employees 18